Understanding how opioid use disorder treatment affects mothers and children
Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomes
This study looks at how different ways of providing treatment for opioid use disorder can affect the health of mothers and their babies during and after pregnancy, using data from over 13,000 pregnant women in Pennsylvania to find ways to make treatment better for families.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10463553 on NIH RePORTER |
What this research studies
This research investigates the impact of opioid use disorder (OUD) treatment on maternal and child health outcomes, particularly during and after pregnancy. It focuses on three key factors: the availability, accessibility, and structure of treatment services. By analyzing healthcare data from Medicaid beneficiaries in Pennsylvania, including over 13,000 pregnant women with OUD, the study aims to identify how these factors influence treatment engagement and subsequent health outcomes for mothers and their infants. The findings could help improve treatment strategies and healthcare policies for women with OUD.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant women with opioid use disorder who are receiving or have received treatment.
Not a fit: Patients who are not pregnant or do not have opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for mothers and infants affected by opioid use disorder.
How similar studies have performed: Previous research has shown that medication-assisted treatment during pregnancy can reduce adverse outcomes, indicating potential for success in this area.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Jarlenski, Marian Patricia — University of Pittsburgh at Pittsburgh
- Study coordinator: Jarlenski, Marian Patricia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.